

This Company Has a Plan to Beat Neuralink at the Brain-Computer Interface Game
42 snips May 16, 2025
Michael Mager, co-founder and CEO of Precision Neuroscience, discusses pioneering brain-computer interfaces designed to assist those with severe mobility issues. He shares the company's vision for making non-invasive brain implants available to millions and the challenges involved in competing with giants like Neuralink. Mager also reflects on recent FDA approvals and the potential for these technologies to revolutionize lives, turning once rare procedures into standard healthcare solutions.
AI Snips
Chapters
Transcript
Episode notes
Brain-Computer Interface Impact So Far
- Brain-computer interfaces (BCI) enable people to control computers using only their thoughts.
- Until recently, BCIs have reached fewer than 100 people due to prototype limits and manufacturing challenges.
Targeting Severely Paralyzed Patients
- Precision Neuroscience targets people who are severely paralyzed who cannot operate digital devices.
- The technology helps these patients rejoin the digital ecosystem through thought control, improving communication and interaction.
Fruit Roll-Up Brain Implant
- Precision Neuroscience uses a cortical surface array that sits atop the brain without penetration.
- This thin 'fruit roll-up'-like film contains 1,024 tiny electrodes about the size of neurons, enabling rich neural activity recording.